2758-18-1
Chemical Structure
3-Methyl-2-cyclopenten-1-one
- CAS No.: 2758-18-1
- Formula:C6H8O
- Molecular Weight:96.13
IUPAC Name: 3-methylcyclopent-2-en-1-one
InChIKey: CHCCBPDEADMNCI-UHFFFAOYSA-N
SMILES: O=C1C=C(C)CC1
Biological Activity: 3-Methyl-2-cyclopenten-1-one is an α,β-unsaturated carbonyl compound and an endogenous metabolite. 3-Methyl-2-cyclopenten-1-one exhibits weak glutathione (GSH) reactivity and urease (Urease) inhibitory activity. 3-Methyl-2-cyclopenten-1-one can be used in research on peptic ulcers and colorectal cancer[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
3-Methyl-2-cyclopenten-1-one | 99.63% | 3-Methyl-2-cyclopenten-1-one is an α,β-unsaturated carbonyl compound and an endogenous metabolite. 3-Methyl-2-cyclopenten-1-one exhibits weak glutathione (GSH) reactivity and urease (Urease) inhibitory activity. 3-Methyl-2-cyclopenten-1-one can be used in research on peptic ulcers and colorectal cancer. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
3-Methyl-2-cyclopenten-1-one (Standard) | ≥98% | 3-Methyl-2-cyclopenten-1-one Standard is the analytical standard of 3-Methyl-2-cyclopenten-1-one (HY-W013014). This product is intended for research and analytical applications. 3-Methyl-2-cyclopenten-1-one is an α,β-unsaturated carbonyl compound and an endogenous metabolite. 3-Methyl-2-cyclopenten-1-one exhibits weak glutathione (GSH) reactivity and urease (Urease) inhibitory activity. 3-Methyl-2-cyclopenten-1-one can be used in research on peptic ulcers and colorectal cancer. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Tanaka T. Urease inhibitory activity of simple α, β-unsaturated ketones. Life sciences. 2003 Oct 24;73(23):2985-90.
- [2]. Hatai M, et al. trans-2-Pentenal, an Active Compound in Cigarette Smoke, Identified via Its Ability to Form Adducts with Glutathione. Chemical & pharmaceutical bulletin. 2019;67(9):1000-1005. [Content Brief]